Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SERPN trial: Rupatadine fumarate for prevention of postherpetic neuralgia
jRCTs021190010Suspended
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of rupatadine in herpes zoster (HZ) and postherpetic neuralgia (PHN). Primary endpoint: Improvement rate of the visual analogue scale (VAS). Started Feb 2020; status: suspended.
02
Drugs
rupatadine
03
Conditions
herpes zoster (HZ)postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on jRCTs021190010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021190010.